Inhibrx Biosciences
NASDAQ: INBX
Healthcare
Biotechnology
Rank
#20100
Market Cap
176.32 M
Volume
122,946
Price
12.18
Change (%)
1.14%
Country or region
United States
United States
Inhibrx Biosciences's latest marketcap:
176.32 M
As of May 2, 2025, Inhibrx Biosciences's market capitalization has reached $176.32 M. According to our data, Inhibrx Biosciences is the 20100th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 176.32 M |
| Revenue (ttm) | 200,000 |
| Net Income (ttm) | 1.69 B |
| Shares Out | 14.48 M |
| EPS (ttm) | 112.62 |
| Forward PE | 0.00 |
| Ex-Dividend Date | May 30, 2024 |
| Earnings Date | May 12, 2025 |
Market Cap Chart
Data Updated: May 2, 2025
Inhibrx Biosciences's yearly market capitalization.
Inhibrx Biosciences has seen its market value drop from $222.93 M to $166.04 M since 2024, representing a total decrease of 25.52% and an annual compound decline rate (CAGR) of 63.42%.
| Date | Market Cap | Change (%) |
|---|---|---|
| April 17, 2025 | $166.04 M | -25.52% |
| December 31, 2024 | $222.93 M |
Company Profile
Frequently Asked Questions
As of May 2, 2025, Inhibrx Biosciences (including the parent company, if applicable) has an estimated market capitalization of $176.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Inhibrx Biosciences global market capitalization ranking is approximately 20100 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2010 |
| IPO Date | August 19, 2020 |
| Employees | 161 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
